No Data
Chunli Medical (01858) will distribute a cash dividend of 0.0830 yuan per share on November 25.
chunli medical (01858) announced that the company will distribute a cash dividend of 0 per share on November 25, 2024...
Hong Kong stocks anomalies | Medical device stocks rise, medical insurance prepayments expected to accelerate enterprise receivables, innovative devices will usher in a new volume of space.
Most medical instruments stocks are rising. As of the time of publication, Microport (00853) is up 5.01% at 6.92 Hong Kong dollars; Sh Pharma (02607) is up 4.05% at 13.36 Hong Kong dollars; Sinopharm (01099) is up 3.14% at 21.35 Hong Kong dollars.
Chunli Medical (688236) 2024 Third Quarter Report Review: Joint continuation labeling and sports medicine centralized procurement led to performance pressure
Subject: The company released the third quarter report of 24 years, Q1-3 24, operating revenue of 0.508 billion yuan (-35.84%), net income attributable to the parent company of 0.061 billion yuan (-66.14%), net profit after deducting non-recurring gains and losses of 0.044 billion yuan (-7
chunli medical (688236.SH): Cumulatively repurchased 0.226% of the company's shares.
Chunli Medical (688236.SH) announced on November 4th that, as of October 31, 2024, the company has repurchased a total of 868,145 shares through the Shanghai Stock Exchange's trading system via centralized competitive bidding trading method, accounting for 0.226% of the total share capital. The highest repurchase price was 15.96 yuan/share, the lowest price was 12.09 yuan/share, and the total amount paid was RMB 12,018,864.19 (excluding transaction costs).
Chunli Healthcare: Third Quarter Report 2024
Third Quarter Report 2024
No Data
No Data